Sophie was a happy healthy five-year-old who had just celebrated her auntie’s wedding as her bridesmaid.
Exactly one month later Sophie was diagnosed with Wilm’s Disease, a form of kidney cancer, following only a few days of feeling unwell. Sophie’s tumour spread from her kidney, up her main vein and into her liver and heart.She immediately began an intensive regime of chemotherapy to try and shrink the tumour. Without surgery to remove the tumour her outlook was very bleak. After several weeks of chemotherapy, Sophie underwent a major operation during which her heart was stopped so that the surgeon could remove the tumour from her heart, liver and her left kidney. The operation was a success but, combined with the radiotherapy and continued chemotherapy, Sophie was very poorly.
Following weeks of touch and go, Sophie, pulled through and became well enough to leave the hospital and go home to her family in Eastleigh. Family life became almost normal; interspersed with regular visits to hospital for chemotherapy, blood tests, transfusions and more.
Life was turned upside down again when a routine scan gave the news we had all dreaded. The cancer had not been beaten and the chemotherapy was no longer working.
Sophie died at home on 9th December 2004.
The aims of Sophie’s Appeal To support the social, emotional and educational welfare of children, their families, nursing and support staff and provide a caring and supporting environment in both local hospitals and in the community. There are so many ways in which the Trust can provide support to parents, carers and schools who find themselves suddenly faced with the reality of cancer.
Treatment to provide additional resources to meet the specific needs of cancer care. The Trust aims to work with two Hampshire hospitals and monies raised can meet their treatment requests. Research Without research…without hope! This is why it is vital to support research and development into treatments and cures for childhood diseases Sophie’s Appeal is funding a research project at the University College London into Wilm’s Disease, a rare childhood cancer.